YXK-26540-61099
5 vaccinations
3 coded responses
41 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 760 / TX
- Registered
- 2020-12-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
SWL-27682-44258
Child or adolescent in my care · Male · 2021-12-10
EFE-18153-00821
Child or adolescent in my care · Male · 2022-07-29
AJT-24694-58642
Child or adolescent in my care · Male · 2022-07-29
Timeline
-
2020-12-31
Registered in v-safe
-
2020-12-31
Dose 1 — Moderna
- 2020-12-31
-
2021-01-01
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-05
- 2021-01-06
- 2021-01-07
- 2021-01-14
- 2021-01-21
-
2021-01-27
Dose 2 — Moderna
- 2021-01-27
-
2021-01-28
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2021-01-29
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
- 2021-01-30
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-02-24
- 2021-03-03
- 2021-03-10
- 2021-04-28
-
2021-07-28
Survey response — 6 months, dose 2MedDRA: Hypertension — Feeling: GoodFree text: HypertensionMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-30
Dose 3 — Moderna
- 2021-11-29
-
2022-02-28
Survey response — 6 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend schoolFree text: Had Covid on 1-24MedDRA releases: 2024-11 · check-in free text available
-
2022-05-17
Dose 4 — Pfizer-BioNTech
- 2022-08-18
-
2022-09-24
Dose 5 — Pfizer-BioNTech
- 2022-09-25
- 2022-09-26
- 2022-09-27
- 2022-09-28
- 2022-09-29
- 2022-09-30
- 2022-10-01
- 2022-10-08
- 2022-10-15
- 2022-10-22
- 2022-10-29
-
2022-11-05
Survey response — day 42, dose 5MedDRA: Fatigue, Hypoacusis, Respiratory tract congestion — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Congestion, difficulty hearing, fatigueMedDRA releases: 2024-11 · check-in free text available
-
2022-12-24
Health check-in — 3 months, dose 5Feeling: FairFree text: Cough, sore throatAdult check-in · check-in free text available
- 2023-03-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-31 | Moderna | |
| 2 | 2021-01-27 | Moderna | |
| 3 | 2021-08-30 | Moderna | No |
| 4 | 2022-05-17 | Pfizer-BioNTech | No |
| 5 | 2022-09-24 | Pfizer-BioNTech | No |
Free text
Release 9 — 6 months, dose 2
Symptoms: Hypertension
Release 11 — 6 months, dose 3
Symptoms: Had Covid on 1-24
Release 12 — day 42, dose 5
Symptoms: Congestion, difficulty hearing, fatigue
Release 12 — 3 months, dose 5
Symptoms: Cough, sore throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Hypertension | ✓ | · | ✓ |
| SD | Hypoacusis | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release